MRGCX
Price
$43.67
Change
-$0.17 (-0.39%)
Updated
Aug 15 closing price
Net Assets
6.7B
VTSAX
Price
$154.04
Change
-$0.41 (-0.27%)
Updated
Aug 15 closing price
Net Assets
1.91T
Interact to see
Advertisement

MRGCX vs VTSAX

Header iconMRGCX vs VTSAX Comparison
Open Charts MRGCX vs VTSAXBanner chart's image
MFS Core Equity C
Price$43.67
Change-$0.17 (-0.39%)
VolumeN/A
Net Assets6.7B
Vanguard Total Stock Mkt Idx Adm
Price$154.04
Change-$0.41 (-0.27%)
VolumeN/A
Net Assets1.91T
MRGCX vs VTSAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MRGCX vs. VTSAX commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRGCX is a StrongBuy and VTSAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSAX has more cash in the bank: 1.91T vs. MRGCX (6.7B). VTSAX pays higher dividends than MRGCX: VTSAX (1.18) vs MRGCX (0.00). MRGCX was incepted earlier than VTSAX: MRGCX (29 years) vs VTSAX (25 years). MRGCX (1.65) is less costly to investors than VTSAX (0.04). MRGCX is a more actively managed with annual turnover of: 30.00 vs. VTSAX (2.00). MRGCX has a lower initial minimum investment than VTSAX: MRGCX (1000) vs VTSAX (3000). VTSAX annual gain was more profitable for investors over the last year : 16.22 vs. MRGCX (3.75). VTSAX return over 5 years is better than : 85.86 vs. MRGCX (39.28).
MRGCXVTSAXMRGCX / VTSAX
Total Expense Ratio1.640.044,100%
Annual Report Gross Expense Ratio1.650.044,125%
Fund Existence29 years25 years-
Gain YTD7.5099.27581%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets6.7B1.91T0%
Annual Yield % from dividends0.001.18-
Returns for 1 year3.7516.2223%
Returns for 3 years20.8846.8245%
Returns for 5 years39.2885.8646%
Returns for 10 years69.15203.1734%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VTGN3.310.36
+12.01%
VistaGen Therapeutics
RXRX5.770.13
+2.30%
Recursion Pharmaceuticals
FTV48.160.36
+0.75%
Fortive Corp
DSS0.83N/A
+0.39%
DSS
CBNK32.68-0.32
-0.97%
Capital Bancorp